ListedSMEMAHALIFE
Mahamaya Lifesciences IPO
Mahamaya Lifesciences IPO is an SME IPO raising ₹70 Cr at ₹108 – ₹114 a share. It listed on 18 Nov 2025 at ₹116, +1.8% against its issue price of ₹114, and trades at ₹171 today (+50.0% since issue). It was subscribed 1.69× in total.
₹114
Issue price
₹171
Price now
+50.0%
Since issue price
18 Nov 2025
Listed on
1.69×Subscribed (final) · all exchanges
Just covered — bids slightly exceed the shares on offer
populated partly populated we hold nothing here — the tab says why
Source documents
What the issuer and the exchanges published. Everything else on this tab is read out of these.
Read-out of the prospectus
A severity-ranked risk register with every item cited to its page, plus litigation counts and rupee exposure and related-party dealings, are being built from the prospectus above. We read prospectuses for current and upcoming issues — historical issues will not gain these sections.